Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more
Xiangyu Medical Co. Ltd. A (688626) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.009x
Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.05 Million) by net assets (CN¥2.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Xiangyu Medical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Xiangyu Medical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Xiangyu Medical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xiangyu Medical Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nedap N.V
F:NE3
|
0.093x |
|
Probe Gold Inc.
TO:PRB
|
-0.217x |
|
Miller Industries Inc
NYSE:MLR
|
0.047x |
|
Power Solutions International, Inc. Common Stock
NASDAQ:PSIX
|
-0.026x |
|
Cecep Environmental Protection Equipment Co Ltd
SHE:300140
|
0.066x |
|
Guanhao Biotech Co Ltd
SHE:300238
|
0.027x |
|
Vishay Precision Group Inc
NYSE:VPG
|
-0.004x |
|
YUNFENG FINANCIAL GRP LTD
F:MNA1
|
N/A |
Annual Cash Flow Conversion Efficiency for Xiangyu Medical Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Xiangyu Medical Co. Ltd. A from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion | CN¥178.59 Million | 0.087x | -19.63% |
| 2023-12-31 | CN¥2.11 Billion | CN¥227.91 Million | 0.108x | +12.36% |
| 2022-12-31 | CN¥1.94 Billion | CN¥186.70 Million | 0.096x | +12.88% |
| 2021-12-31 | CN¥1.95 Billion | CN¥165.88 Million | 0.085x | -70.72% |
| 2020-12-31 | CN¥743.29 Million | CN¥216.40 Million | 0.291x | +2.18% |
| 2019-12-31 | CN¥547.28 Million | CN¥155.94 Million | 0.285x | +59.30% |
| 2018-12-31 | CN¥414.81 Million | CN¥74.20 Million | 0.179x | -70.12% |
| 2017-12-31 | CN¥99.09 Million | CN¥59.31 Million | 0.599x | -- |